Harris v. Innovate Biopharmaceuticals, Inc.
This text of Harris v. Innovate Biopharmaceuticals, Inc. (Harris v. Innovate Biopharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
IN THE SUPREME COURT OF THE STATE OF DELAWARE
M. SCOTT HARRIS, M.D., and § MIDDLEBURG CONSULTANTS, § No. 459, 2019 INC., § § Plaintiffs Below, § Court Below: Superior Court Appellants, § of the State of Delaware § v. § C.A. No. N19C-01-055 (N) § INNOVATE BIOPHARMACEUTI- § CALS, INC., a Delaware Corporation, § § Defendant Below, § Appellee. § §
Submitted: April 29, 2020 Decided: May 5, 2020
Before VAUGHN, TRAYNOR, and MONTGOMERY-REEVES, Justices.
ORDER
This 5th day of May 2020, the Court having considered this matter on the briefs
filed by the parties has determined that the final judgment of the Superior Court
should be affirmed on the basis of and for the reasons assigned by the Superior Court
in its order dated October 15, 2019.
NOW, THEREFORE, IT IS HEREBY ORDERED that the judgment of the
Superior Court be, and the same hereby is, AFFIRMED.
BY THE COURT:
/s/ James T. Vaughn, Jr. Justice
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
Harris v. Innovate Biopharmaceuticals, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/harris-v-innovate-biopharmaceuticals-inc-del-2020.